<DOC>
	<DOCNO>NCT00023296</DOCNO>
	<brief_summary>This study test whether inhale nitric oxide ( NO ) gas mixed room air improve pulmonary hypertension ( high blood pressure lung ) patient sickle cell anemia . Patients sickle cell disease 18 year age old may eligible participate one part three-stage study , follow : Stage 1 Patients undergo follow test determine cause pulmonary hypertension : blood test ; echocardiogram ( heart ultrasound ) ; asthma test ; oxygen breathing study measurement arterial blood oxygen level ; chest X-ray ; lung scan ; MRI heart ; 6-minute walk test ; night-time oxygen measurement sleeping ; exercise study . Stage 2 Patients detailed MRI evaluation heart admit NIH Clinical Center intensive care unit ( ICU ) follow test : A plastic tube place vein patient 's arm another tube place deep neck leg vein . A third tube insert vein heart lung artery measure blood pressure heart lungs directly . Following baseline measurement , three medication ( inhaled oxygen , infused prostaglandin , inhale NO ) deliver 2 hour , separate 30-minute washout period . A small blood sample draw NO administration . Patients treat nitric oxide treatment work may receive monthly exchange transfusion 3 month . For procedure , 3 5 five unit patient 's blood remove replace 3 5 unit sickle hemoglobin . Some patient respond NO exchange transfusion may receive alternative therapy , oxygen , prostacyclin , L-arginine , bosentan sidenafil . Stage 3 Patients remain ICU catheter place another 24 hour . During time breathe NO . Lung pressure measure every 4 hour blood drawn every 8 hour . They stay hospital 1 day observation . Patients breathe nitric oxide continuously 2 month use tank gas deliver NO tube place nose . They may home outpatient basis may remain hospital 2 month . Patients echocardiogram blood test every week 6-minute walk test every 2 week .</brief_summary>
	<brief_title>Nitric Oxide Transfusion Therapy Sickle Cell Patients With Pulmonary Hypertension</brief_title>
	<detailed_description>Sickle cell anemia autosomal recessive disorder common genetic disease affect African-Americans . Approximately 0.15 % African-Americans homozygous sickle cell disease , 8 % sickle cell trait . Acute pain crisis , acute chest syndrome ( ACS ) , secondary pulmonary hypertension common complication sickle cell anemia . Pulmonary hypertension identify major cause death adult sickle cell disease . Inhaled nitric oxide ( NO ) propose possible therapy primary secondary pulmonary hypertension . Furthermore , number recent study suggest NO may favorable impact sickle red cell molecular level could improve abnormal microvascular perfusion characteristic sickle cell anemia . In addition , chronic exchange transfusion therapy may reduce progression and/or severity pulmonary hypertension patient . This clinical trial design ( 1 ) determine pathophysiologic process associate potentially contribute secondary pulmonary hypertension adult patient sickle cell anemia , compare cardio-pulmonary status patient sickle cell disease without pulmonary hypertension ( 2 ) determine relative acute vasodilatory effect oxygen , intravenous prostacyclin , inhale nitric oxide pulmonary artery pressure hemodynamic parameter patient secondary pulmonary hypertension sickle cell anemia , ( 3 ) determine effect two month inhale nitric oxide pulmonary artery pressure , hemodynamic parameter , exercise tolerance , symptoms patient population , ( 4 ) determine effect three month exchange transfusion pulmonary artery pressure , hemodynamic parameter , exercise tolerance , symptoms patient receive fail respond NO therapy .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>INCLUSION CRITERIA For Stage I Pulmonary Hypertension Subjects : Male female , 18 year age old . Diagnosis sickle cell disease ( electrophoretic documentation SS , SC , S betahalassemia genotype require ) . Hematocrit great 18 % ( absolute reticulocyte count great 100,000/ml hematocrit 1824 % ) . Mild severe pulmonary hypertension systolic pulmonary artery pressure great equal 30 mm Hg ( tricuspid regurgitant velocity great 2.5 m/sec , assume right atrial pressure great 5 cm H20 ) right ventricular enlargement . We compare study control group sickle cell patient pulmonary hypertension . For Stage I Controls : Males female , 18 year age old . Diagnosis sickle cell disease ( electrophoretic documentation SS , SC , S betahalassemia genotype require ) . Hematocrit great 18 % ( absolute reticulocyte count great 100,000/ml hematocrit 1824 % ) . Tricuspid regurgitant velocity less equal 2.4 m/sec , match age , gender , hydroxyurea therapy status fetal hemoglobin level pulmonary hypertension subject . For Stage II : Male female , 18 year age old . Diagnosis sickle cell disease ( electrophoretic documentation SS , SC , S betathalassemia genotype require ) . Hematocrit great 18 % ( absolute reticulocyte count great 100,000/ml hematocrit 1824 % ) . Mild severe pulmonary hypertension systolic pulmonary artery pressure great equal 30 mm Hg ( tricuspid regurgitant velocity great 2.5 m/sec , assume right atrial pressure great 5 cm H20 ) right ventricular enlargement . For Stage III : Male female , 18 year age old . Diagnosis sickle cell disease ( electrophoretic documentation SS , SC , S betathalassemia genotype require ) . Hematocrit great 18 % ( absolute reticulocyte count great 100,000/ml hematocrit 1824 % ) . Able walk least 100 six minute baseline . Mild severe pulmonary hypertension mean pulmonary artery pressure great equal 25 mm Hg , measure pulmonary artery catheterization . Pulmonary artery wedge pressure leave ventricular enddiastolic pressure less equal 18 mm Hg echocardiographic criterion exclude leave ventricular dysfunction . EXCLUSION CRITERIA For Stage I Current pregnancy lactation For Stage II Current pregnancy lactation Any follow medical condition : Significant renal insufficiency ( patient hemodialysis estimate creatinine clearance le 30 % normal ; Stroke within last six week ; New diagnosis pulmonary embolism within last three month ; History retinal detachment . Hematocrit le 18 % eligible study ; may return evaluation later date . Patients take prostacyclin ( inhaled intravenous ) exclude study . Patients take calcium channel blocker allow participate provide stable dose great one month . For Stage III Current pregnancy lactation Any follow medical condition : Significant renal insufficiency ( patient hemodialysis estimate creatinine clearance le 30 % normal ; Stroke within last six week ; Left ventricular enddiastolic pressure great equal 18 mm Hg ( determine pulmonary artery occlusion pressure ) echocardiographic criterion leave ventricular dysfunction ; New diagnosis pulmonary embolism within last three month ; History retinal detachment ; Hematocrit le 18 % eligible study ; may return evaluation later date . Patients take prostacyclin ( inhaled intravenous ) exclude study . Patients take calcium channel blocker allow participate provide stable dose great one month . Patients research study treatment pulmonary hypertension treatment specific pulmonary hypertension exclude stage III study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 9, 2015</verification_date>
	<keyword>Acute Chest Syndrome</keyword>
	<keyword>Blood Flow</keyword>
	<keyword>Nitric Oxide</keyword>
	<keyword>NO Therapy</keyword>
	<keyword>Vaso-Occlusive Crisis</keyword>
	<keyword>Sickle Cell Anemia</keyword>
	<keyword>Sickle Cell</keyword>
	<keyword>ACS</keyword>
	<keyword>Pulmonary Hypertension</keyword>
</DOC>